Storia in 20 fonti

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

Novo alleges Lilly compared the highest approved doses of its medicines with lower doses of Novo’s Wegovy and Ozempic while omitting newer, higher-dose versions that Novo says deliver greater weight loss.

Raccontata da

economictimes.indiatimes.com

zerohedge.com

france24.com

efe.com

lecho.be+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

nbcnews.comStai leggendo1 mese fa

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

originale

Timeline cronologica

martedì 21 luglio 2026·index.hr
Proizvođač Ozempica tužio konkurenta
FARMACEUTSKA tvrtka Novo Nordisk tuži konkurenta Eli Lilly zbog, kako navodi, lažnog prikazivanja njegovih lijekova za mršavljenje kao superiornijih na temelju zastarjelih studija.
martedì 21 luglio 2026·biopharmadive.com
Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that…

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

Confronto fonti

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

Timeline cronologica

Proizvođač Ozempica tužio konkurenta

Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs

Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drug

Novo Nordisk sues Eli Lilly over ‘deliberately false’ weight-loss drug ads

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads

Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads

Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive Advertising

Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads

Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drug

GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign

Pharma heavyweights clash over anti-obesity drug ads

El fabricante de Ozempic demanda a su rival Eli Lilly por publicidad engañosa - EFE

Novo Nordisk intente un procès à Eli Lilly pour publicité mensongère sur ses traitements anti-obésité

Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads

Pharmaindustrie: Novo Nordisk verklagt US-Rivalen Eli Lilly

Novo Nordisk porta Eli Lilly in tribunale: pubblicità ingannevole sui farmaci anti-obesità | MilanoFinanza News

Novo Nordisk, fabricante de Ozempic y Wegovy, demanda a Eli Lilly; acusa publicidad engañosa sobre medicamentos contra obesidad y diabetes

Ozempic maker sues US rival over ad campaign

Novo Nordisk, la creadora de Ozempic, demanda a su rival Eli Lilly en Estados Unidos por publicidad engañosa

Novo Nordisk suing Eli Lilly over GLP-1 ‘outdated’ advertisements - UPI.com

Novo Nordisk demanda a Eli Lilly por “publicidad engañosa” de Zepbound frente a Ozempic y Wegovy